As director of Pew's prescription drug abuse project, Reilly works on federal and state initiatives to reduce the health and economic consequences of prescription drug abuse.
Prior to joining Pew, Reilly worked on issues related to the safety and quality of medication use for the American Society of Health-System Pharmacists in Bethesda, Maryland. Areas of focus included the development of clinical policy, dissemination of best practices to improve patient outcomes, and coordination of initiatives aimed at ensuring the availability and integrity of drug products. In this role, she coordinated the society’s work in support of rescheduling hydrocodone combination products from Schedule III to Schedule II to improve the safe and appropriate use of those therapies. In addition, she led development of policy that called on clinicians to increase efforts to combat prescription drug abuse while also ensuring patient access to needed pain therapies.
Reilly received her bachelor’s degree in pharmacy from Temple University in Philadelphia, Pennsylvania. She is currently enrolled in the master’s program in health and medical policy at George Mason University.
Methadone, a synthetic opioid historically used to treat heroin addiction, is also prescribed for chronic, noncancer pain. While methadone accounts for just 2 percent of opioid pain reliever prescriptions, it is responsible for nearly one-third of all overdose deaths. On Nov. 17, the National Conference of State Legislators hosted a webinar featuring Cynthia Reilly, director of The Pew... Read More
On Oct. 15, Cynthia Reilly, director of The Pew Charitable Trusts’ prescription drug abuse project, submitted written testimony to the Senate Finance Subcommittee on Health Care regarding policy proposals intended to help curb prescription opioid abuse. Read More
Using Patient Review and Restriction Programs to Protect Patients at Risk of Opioid Misuse and Abuse
Each year, more than 16,000 people in the United States die from prescription opioid overdoses. As one strategyto minimize these events and other harms associated with prescription drug abuse, public and private insuranceplans are using patient review and restriction (PRR) programs to encourage the safe use of opioids and othercontrolled substances. PRR programs identify patients who are at risk... Read More